Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.14 USD | +1.58% | +3.84% | -18.09% |
May. 15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
May. 15 | T2 Biosystems Shares Rise After CRG Servicing Ups Stake | MT |
Financials (USD)
Sales 2024 * | 10.5M | Sales 2025 * | 23.1M | Capitalization | 87.72M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -47M | EV / Sales 2024 * | 8.35 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.8 x |
P/E ratio 2024 * |
-1.39
x | P/E ratio 2025 * |
-3.67
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.09% |
Latest transcript on T2 Biosystems, Inc.
1 day | +1.58% | ||
1 week | +3.84% | ||
1 month | +53.20% | ||
3 months | +1.98% | ||
6 months | +45.20% | ||
Current year | -18.09% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.14 | +1.58% | 84,601 |
24-05-30 | 5.06 | -0.59% | 54,217 |
24-05-29 | 5.09 | +0.59% | 73,860 |
24-05-28 | 5.06 | +2.22% | 165,893 |
24-05-24 | 4.95 | -4.07% | 150,350 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.09% | 87.72M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- TTOO Stock